Ichim TE, Solano F, Glenn E, et al. Stem cell therapy for autism. J Transl
Med. 2007; 5: 30. doi: 10.1186/1479-5876-5-30.
Siniscalco D, Bradstreet JJ, and Antonucci N. Therapeutic role of
hematopoietic stem cells in autism spectrum disorder-related inflammation. Front
Immunol. 2013; 4: 140. doi: 10.3389/fmmu.2013.00140.
Sharma A, Gokulchandran N, Chopra G, et al. Administration of autologous
bone marrow-derived mononuclear cells in children with incurable neurological
disorders and injury is safe and improves their quality of life. Cell Transplant.
2012; 21 Suppl 1: S79-90. doi: 10.3727/096368912X633798.
Simberlund J, Ferretti CJ, and Hollander E. Mesenchymal stem cells in
autism spectrum and neurodevelopmental disorders: pitfalls and potential
promises. World J Biol Psychiatry. 2015; 1-8.
Chương 14
Lazebnik LB, Kniazev OV, Parfenov AI, et al. [Transplantation of allogeneic
mesenchymal stem cells from the bone marrow increases duration of remission
and reduces the risk of ulcerative colitis relapse]. Eksp Klin Gastroenterol. 2010;
(3): 5-10.
Lazebnik LB, Kniazev OV, Konoplyannikov AG, et al. [Allogeneic
mesenchymal stromal cells in patients with ulcerative colitis: two years of
observation]. Eksp Klin Gastroenterol. 2010; (11): 3-15.
Knyazev OV, Parfenov AI, Konoplyannikov AG, Boldyreva ON. [Use of
mesenchymal stem cells in the combination therapy of ulcerative colitis]. Ter
Arkh. 2016; 88(2): 44-8.
Gonçalves Fda C, Schneider N, Pinto FO, et al. Intravenous vs
intraperitoneal mesenchymal stem cells administration: what is the best route for
treating experimental colitis? World J Gastroenterol. 2014; 20(48): 18228-39.
doi: 10.3748/wjg.v20.i48.18228.
He XW, He XS, Lian L, Wu XJ, Lan P. Systemic infusion of bone marrow-
derived mesenchymal stem cells for treatment of experimental colitis in mice.
Dig Dis Sci. 2012 Dec; 57(12): 3136-44. doi:10.1007/s10620-012-2290-5.
